CRYOPORT, INC. (NASDAQ:CYRX) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07
Cryoport, Inc. (the “Company”) commenced its 2017 Annual Meeting of Stockholders (“Annual Meeting”) on September 12, 2017. The final voting results for each of the proposals submitted to a vote of stockholders at the Annual Meeting, each of which is described in detail in the Proxy, are set forth below.
Proposal No. 1: Election of the Board of Directors to serve until the Company’s 2018 Annual Meeting of Stockholders. The individuals listed below were elected to serve as directors of the Company until the next annual meeting of the stockholders and until their successors are duly elected and qualified:
|
Directors |
Votes For |
Votes Withheld |
Broker Non-Votes |
|||||||||
| Richard Berman | 8,430,748 | 1,220,370 | 5,927,061 | |||||||||
| Robert Hariri, M.D., PhD. | 8,215,284 | 1,435,834 | 5,927,061 | |||||||||
| Ramkumar Mandalam, PhD. | 9,318,405 | 332,713 | 5,927,061 | |||||||||
| Jerrell W. Shelton | 9,629,368 | 21,750 | 5,927,061 | |||||||||
| Edward J. Zecchini | 9,316,685 | 334,433 | 5,927,061 | |||||||||
|
Votes For |
Votes Against |
Abstain |
Broker Non-Votes |
|||||||||
| Proposal No. 2: Ratify the Audit Committee’s selection of KMJ Corbin & Company LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017. This proposal was approved. | 15,553,303 | 12,488 | 12,388 | – | ||||||||
| Proposal No. 3: To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Proxy Statement for the 2017 Annual Meeting of Stockholders. This proposal was approved. | 8,798,240 | 708,587 | 144,291 | 5,927,061 |
About CRYOPORT, INC. (NASDAQ:CYRX)
Cryoport, Inc. (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients. The Company’s Cryoport Express Solution includes a cloud-based logistics operating platform, which is branded as the Cryoportal. The Company’s Cryoport Express Solutions are made up of the Cryoportal software platform, Cryoport Express Shippers, Cryoport Express Smart Pak data loggers and its life sciences cold chain logistics expertise. The Cryoportal is used by the Company, its clients and its business partners to automate the entry of orders, prepare customs documentation, and to facilitate status and location monitoring of shipped orders while in transit. CRYOPORT, INC. (NASDAQ:CYRX) Recent Trading Information
CRYOPORT, INC. (NASDAQ:CYRX) closed its last trading session up +0.03 at 9.17 with 294,385 shares trading hands.
